Category: CovidienSyndicate content

Covidien recalls flush syringes

August 20, 2013 by Sony Salzman

Covidien warns customers in the U.S. and Bermuda that some of its Monoject syringes were mislabeled and not properly sterilized, prompting the company to recall 6 lots of the device.

Covidien recalls flush syringes

Covidien (NYSE:COV) recalled some lots of its Monoject syringes after discovering a sterilization mishap and labeling problem.

The issues affected 6 lots in shipments that went out to customers in the U.S. and Bermuda, the Mansfield, Mass.-based medical products giant said.

Jury hands Covidien's ev3 subsidiary a possible $275M loss

August 13, 2013 by Brad Perriello

A Delaware state jury finds that Covidien's ev3 subsidiary broke its deal for a $175 million milestone payment to Appriva Medical, awarding the milestone nut plus interest.

Jury hands Covidien's ev3 subsidiary a possible $265M loss

Covidien (NYSE:COV) is on the hook for a $175 million milestone owed by subsidiary ev3 Inc. to a company it acquired 11 years ago, plus another possible $100 million in interest, after a Delaware jury's decision last May.

CAS Medical wins a legal round against Covidien's Nellcor

August 12, 2013 by Brad Perriello

A federal judge tosses 1 count of a patent infringement lawsuit filed by Covidien's Nellcor subsidiary against CAS Medical over patient monitoring technology.

MassDevice.com Legal News

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Boston Scientific, Covidien get in on SetPoint Medical's $27M round

August 8, 2013 by Brad Perriello

SetPoint Medical raises $27 million, including contributions from Boston Scientific, Covidien and GlaxoSmithKline's new venture investing arm.

Boston Scientific, Covidien get in on SetPoint Medical's $27M round

SetPoint Medical said Boston Scientific (NYSE:BSX) and Covidien (NYSE:COV) were among the participants in a $27 million funding round.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien gains on Q3 earnings beat

August 1, 2013 by Brad Perriello

Covidien shares are up this morning after the medical device company beat earnings expectations with its fiscal 3rd-quarter results.

Covidien gains on Q3 earnings beat

Covidien (NYSE:COV) shares gained on Wall Street today after the medical device company said its fiscal 3rd-quarter earnings beat analysts' predictions.

Mansfield, Mass.-based Covidien posted profits of $396.0 million, or 84¢ per share, on sales of $2.58 billion during the 3 months ended June 28.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

GPO: Premier awards Technology Breakthroughs contract to Olympus America

July 31, 2013 by Sony Salzman

Group purchasing organization Premier inked a deal with Olympus America for the company's Thunderbeat surgical tool, signing it up under the GPO’s program for innovative new technologies.

PremierHealthcareAlliance

Olympus America, a Center Valley, Pa.-based commercial camera and medical supply maker, landed a contract to supply surgical tools to members of group purchasing organization Premier healthcare alliance.

ArjoHuntleigh taps Covidien executive | Personnel Moves

July 19, 2013 by Sony Salzman

ArjoHuntleigh lured a former Covidien executive as its new president of North American operations.

fired/hired

Illinois healthcare products maker ArjoHuntleigh hired Rick Lytle, a former Covidien (NYSE:COV) executive, as the new president of company operations in the U.S. and Canada.